All
- All
- Articles
- Calendar
- Compliance
- Newsletter
- Position Statements
- Press Release
- Regulatory
- Uncategorized
AAHP Addresses OTC Homeopathic Drug Products for Asthma
The American Association of Homeopathic Pharmacists (AAHP), representing the principal manufacturers and distributors of homeopathic medicines in the United States, said today it fully supports...
AAHP Response to Australian Study on Homeopathic Effectiveness
National Health and Medical Research Council (NHMRC) Information Paper: Evidence on the effectiveness of homeopathy for treating health conditions On March 11, 2015, the Australian...
FDA’s Quality Metrics Initiative – From Compliance to Performance
By Mark Land, VP Operations and Regulatory Affairs at Boiron The 2012 Food Drug Administration Safety and Innovation Act (FDASIA) gave FDA new tools to...
Stability Testing
The AAHP office just received a copy of an article, Stability Testing of Medicinal Products According to Homeopathic Principles; this appeared in Pharmaceutical Industry (71,...
Deployment of FDA Inspection Resources
By Mark Land, VP Operations and Regulatory Affairs at Boiron A primary mission of the Food and Drug Administration is to conduct comprehensive regulatory coverage...
FDA Establishes Unique Facility Identifier
In November, the Food and Drug Administration published a Guidance for Industry entitled: Specification of the Unique Facility Identifier (UFI) System for Drug Establishment Registration....
Publications Review – A Treasure Source
AAHP Board member Mary Beth Watkins notes two periodicals containing articles that may be of interest to industry members. In the American Journal of Homeopathic...